SecBot SecBot

POP Act

H.R. 5433 Rep. Val Hoyle (D-OR-4) In committee
  1. Introduced Sep 17
  2. Committee Sep 17
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Sep 17, 2025Next: House vote
406d ago Sep 17, 2025: Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 5 filings
Member trades
1trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Consumer & Retail 1
Search all 1 companies, their asks and price moves Subscribe

Summary

This bill makes it illegal for any person to own both a health insurance issuer and certain health care providers (or their management services organizations) that participate in Medicare, and requires divestment of one or the other. It also adds a similar prohibition to Medicare Advantage and Part D contracts, and gives enforcement powers to federal and state authorities.

Sec. 2, Prohibition on common ownership: It is unlawful for any person to own, operate, or control both an applicable provider (or its management services organization) and a health insurance issuer. Violators must divest one of them within 2 years if acquired before the bill's enactment, or within 1 year if acquired after. The Inspector General of HHS, the Assistant Attorney General for Antitrust, the FTC, or a state attorney general can sue in federal court for an order to stop the violation, force divestment, and disgorge any revenue from health care services during the violation. Disgorged funds go into an FTC fund for the health care needs of the harmed community.

Sec. 2, FTC review: Any required divestment must be reported to the FTC and the Assistant Attorney General under the Clayton Act, regardless of normal thresholds. The divestment period is paused during any waiting period under that Act. The FTC and Assistant Attorney General must review the effect on competition, financial viability, and public interest of the divestiture and any subsequent acquisition.

Sec. 2, Rulemaking and enforcement: The FTC must issue rules to carry out this section. Nothing in the section limits other legal authorities. For Medicare Advantage, starting in 2026, the Secretary cannot contract with or pay a Medicare Advantage organization that owns an applicable provider or is owned by someone who does. Each organization must certify compliance, and false claims from violators are considered false or fraudulent. The same prohibition applies to Medicare Part D plans.

Sec. 2, Definitions: 'Applicable provider' means any entity paid for services under Medicare Part B or a Medicare Advantage plan, but excludes hospitals, critical access hospitals, rural emergency hospitals, durable medical equipment suppliers, and pharmacies. 'Health insurance issuer' is defined by the Public Health Service Act. 'Management services agreement' is a contract for management or administrative services supporting health care. 'Management services organization' is any entity that contracts with an applicable provider for such services. 'Person' is defined by the Sherman Act.

Summary of the bill text as introduced in House (Sep 17, 2025), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.